Position in ABCL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$785,000
+$670,800 QoQ
Shares Held
100,000
+400.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4
of 24 holders
Holding Since
Sep 2023
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COOKSON PEIRCE & CO INC holds $47,400,065 across 10 Biotechnology names. ABCL ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
398,854 | $22,363,743 | |
| 2 | INCY |
Incyte Corp
|
126,885 | $14,383,683 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
11,822 | $3,736,815 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
4,898 | $1,820,439 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
104,992 | $1,781,714 | |
| 6 | LEGN |
Legend Biotech Corp
|
30,000 | $866,400 | |
| 7 | ABCL |
AbCellera Biologics Inc.
This page
|
100,000 | $785,000 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
60,000 | $618,000 |
All Filings in ABCL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $785,000 | 100,000 | Shares | Sole | 2026-07-23 | |
| 2023-12-31 | $114,200 | 20,000 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $92,000 | 20,000 | Shares | Sole | 2023-11-07 | |
| No filing history on record for this holder in this stock. | ||||||